Vaccine Adjuvants Market by Application and Geography - Forecast and Analysis 2020-2024

The global vaccine adjuvants market has the potential to grow by USD 401.94 million during 2020-2024, and the market’s growth momentum will accelerate throughout the forecast period.

This report provides a detailed analysis of the market by geography (Asia, Europe, North America, and ROW) and application (infectious diseases, cancer, and other diseases). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Agenus Inc., Avanti Polar Lipids Inc., Croda International Plc, CSL Ltd., GlaxoSmithKline Plc, InvivoGen, Merck KGaA, OZ Biosciences SAS, SEPPIC SA, and Vaxine Pty Ltd.

Market Overview

Browse TOC and LoE with selected illustrations and example pages of vaccine adjuvants market

Request a FREE sample now!

Market Competitive Analysis

The market is concentrated, and the degree of concentration will decrease during the forecast period. Established vendors are adopting collaborations as a business strategy to expand their product portfolios and strengthen their businesses. OZ Biosciences SAS, SEPPIC SA, and Vaxine Pty Ltd. are a few of the major market participants. Although the accelerating growth momentum will offer immense growth opportunities, the side-effects of adjuvants will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

To help clients improve their market positions, this vaccine adjuvants market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this vaccine adjuvants market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.

This report provides information on the production, sustainability, and prospects of several leading vaccine adjuvants companies, including:

• Agenus Inc.
• Avanti Polar Lipids Inc.
• Croda International Plc
• CSL Ltd.
• GlaxoSmithKline Plc
• InvivoGen
• Merck KGaA
• OZ Biosciences SAS
• SEPPIC SA
• Vaxine Pty Ltd.

Vaccine Adjuvants Market: Segmentation by Region

For more insights on the vaccine adjuvants market share of various regions Request for a FREE sample now!

North America was the largest market for vaccine adjuvants in 2019, and the region will continue to offer maximum growth opportunities to market vendors during the forecast period. The increasing number of immunization programs, rising use of adjuvants in vaccines, and a strong prevalence of infectious diseases will increase sales of vaccine adjuvants, contributing to the market growth.

Over 55% of the market’s growth will originate from North America during the forecast period. The US, Canada, and Mexico are the key markets for vaccine adjuvants in North America. Market growth in this region will be faster than the growth of the market in ROW.

Vaccine Adjuvants Market: Segmentation by Application

Request for a FREE sample and Get more information on the market contribution of various applications

The rising need to prevent the spread of infectious diseases across the world has created a need for the development of pathogen-specific immune response with long-lasting effects against the infection. This is one of the crucial factors that gave rise to vaccine adjuvants. Moreover, there is a significant need for novel adjuvants for future vaccines. Therefore, R&D activities for the formulation of novel adjuvants are growing. These factors will contribute to the market growth during the forecast period.

The market growth by the infectious diseases segment will be faster than the growth of the market by cancer and other diseases segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the vaccine adjuvants market size.

Vaccine Adjuvants Market: Key Drivers and Trends

The increasing number of infectious diseases has been a significant cause of the number of deaths in infants and children. As a result, many governments, organizations, and vendors have taken initiatives to raise awareness about immunization programs and improve access to vaccines. For instance, in 2019, the American College of Obstetricians and Gynecologists joined the American Medical Women’s Association to launch the first human papillomavirus prevention week in the US to provide information and generate awareness about the human papillomavirus vaccination programs. Similarly, the World Immunization Week, celebrated at the end of April every year, raises awareness about immunization against a host of diseases. Such awareness programs have increased sales of vaccine adjuvants.

The other crucial factor contributing to the growth of the market is the ability of adjuvants in vaccines to enhance the immunogenicity of highly purified antigens and improve the efficacy of vaccines by neutralizing antibodies. As a result, the vaccine adjuvants market growth will be substantial over the forecast period.

• The development of nanoparticle adjuvants is one of the key vaccine adjuvants market trends.
• Nanoparticle adjuvants intensify an individual’s specific immune responses against pathogen infections and malignancy.
• Due to the high efficacy of vaccine adjuvants in potentiating a strong immune response in individuals, vendors are focusing on developing new-generation adjuvants to create a more potent antigen-specific response.
• Moreover, nanotechnology offers a multifunctional stage for the integration of the desired adjuvant activities. Nanoparticles for antigen delivery can provide high bioavailability as well as constant and controlled-release profiles.
• Thus, the increasing use of nanotechnology for immunotherapy and prophylactic immunization has led to the manipulation of nanostructures, which provides opportunities for unique designs of nano-adjuvants for vaccines.
• During 2020-2024, the market will grow at a CAGR of almost 11%.

Request for a FREE sample now!

Vaccine Adjuvants Market: Key Highlights of the Report for the Forecast Period 2020-2024

• CAGR of the market during the forecast period 2020-2024
• Detailed information on factors that will accelerate the vaccine adjuvants market growth during the next five years
• Precise estimation of the global vaccine adjuvants market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the vaccine adjuvants industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market’s competitive landscape and detailed information on vendors
• Comprehensive details of factors that will challenge the growth of vaccine adjuvants vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch